IL1B and systemic-onset juvenile idiopathic arthritis: In this regard, the concept of a “window of opportunity,” namely, as the period of time after the disease onset during which starting IL-1 inhibition may be more effective, has been proposed for patients with Still’s disease, at least for patients with pediatric onset (19, 31–33).